Thymic Cancer

12 registered clinical trials studyying Thymic Cancer — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062	Rongrong Zhou	N/A
Recruiting	PT-112 in Subjects With Thymoma and Thymic Carcinoma NCT05104736	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma NCT04417660	National Cancer Institute (NCI)	Phase 2
Terminated	Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumor NCT04234113	SOTIO Biotech AG	Phase 1
Terminated	Cardiac MRI Biomarker Testing (GCC 1618) NCT02688166	University of Maryland, Baltimore	—
Unknown	A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor NCT03219554	Samsung Medical Center	Phase 2
Recruiting	Molecular Analysis and Treatment Options of Thymic Malignancies NCT05667948	Shanghai Chest Hospital	—
Completed	Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors NCT02233842	National Cancer Institute (NCI)	—
Completed	Genetic Evaluation of Families With Endocrine Cancers NCT01794676	Jersey Shore University Medical Center	—
Terminated	Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies NCT01165658	M.D. Anderson Cancer Center	Phase 1
Completed	Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity NCT01163552	St. Luke's-Roosevelt Hospital Center	Phase 2
Completed	A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Can NCT00369889	Indiana University School of Medicine	Phase 2